Fgf20 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FGF20 (Fibroblast Growth Factor 20) is a member of the fibroblast growth factor family that is highly expressed in the brain, particularly in the substantia nigra. FGF20 has been studied extensively for its neurotrophic effects on dopaminergic neurons and its potential role in Parkinson's disease pathogenesis and therapy.
[^2]
| Property | Value |
|----------|-------|
| **Gene Symbol** | FGF20 |
| **Full Name** | Fibroblast Growth Factor 20 |
| **Chromosomal Location** | 8p21.3 |
| **NCBI Gene ID** | 56844 |
| **OMIM ID** | 605830 |
| **Ensembl ID** | ENSG00000078579 |
| **UniProt ID** | Q9NP95 |
| **Aliases** | FGF-20, Fibroblast Growth Factor 20 |
FGF20 is a member of the FGF family of growth factors, which are involved in various developmental and regenerative processes. Unlike other FGFs, FGF20 has a restricted expression pattern with high levels in the brain.
- Dopaminergic neuron survival: Promotes survival and function of dopaminergic neurons
- Neuroprotection: Protects neurons from various insults
- Neurotrophic effects: Supports neuronal differentiation and maintenance
- Midbrain development: Critical for substantia nigra development
- Synaptic plasticity: Involved in activity-dependent synaptic changes
FGF20 signals through fibroblast growth factor receptors (FGFRs):
- FGFR1: Primary receptor for FGF20 in the brain
- FGFR2: Secondary receptor in some cell types
- FGFR3: Expressed in certain brain regions
- Genetic association: FGF20 polymorphisms have been associated with PD risk in some populations
- Neuroprotective effects: FGF20 protects dopaminergic neurons from toxin-induced damage
- Substantia nigra expression: High expression in SNpc makes it relevant to PD
- Therapeutic potential: FGF20 delivery has been explored as a neuroprotective strategy
- LRRK2 interaction: May interact with PD-associated LRRK2 mutations
- Neurotrophic support: FGF20 may support cholinergic neuron survival
- Expression changes: Altered FGF20 expression in AD brain
- Synaptic function: May modulate synaptic plasticity affected in AD
- Depression: FGF20 expression altered in depression models
- Stroke: Neuroprotective effects in ischemic models
- Neurogenesis: Supports adult neurogenesis in some brain regions
FGF20 has a unique, region-specific expression pattern:
- Substantia nigra pars compacta: Highest expression in the brain
- Striatum: Moderate expression
- Hippocampus: Lower expression
- Cortex: Low expression
- Peripheral tissues: Limited expression
- Neuroprotective therapy: FGF20 delivery to protect dopaminergic neurons
- Gene therapy: AAV-mediated FGF20 expression
- Small molecule agonists: FGFR agonists to enhance FGF20 signaling
- Combination therapy: FGF20 with other neurotrophic factors
[1] Sleeman, I.J. et al. (2019). FGF20 and Parkinson's disease. Mov Disord 34, 1567-1577.
[2] Ohmachi, S. et al. (2018). Neuroprotective effects of FGF20 in models of Parkinson's disease. J Neurosci 38, 9422-9433.
[3] Murase, M. et al. (2020). FGF20 gene variants and Parkinson's disease risk. Neurology 95, e2345-e2353.
[4] Zheng, L. et al. (2017). FGF20 promotes dopaminergic neuron survival. Mol Neurobiol 54, 4568-4579.
[5] Itoh, N. & Ohta, H. (2019). Roles of FGF20 in neuronal survival and plasticity. Neurochem Int 131, 104548.
The study of Fgf20 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.